Home

Baker Bros. Advisors reported a 23.5% stake in Prelude Therapeutics PRLD · 10,269,968 sh · amendment

Trade details

Type
5% stake report
Report
13D · amendment
Stake
23.5%
Last report
No earlier report
Shares held
10,269,968 sh
Class
Common Stock, $0.0001 par value per share
Event date
25/06/12
Filed
25/06/13

23.5% stake

Prelude Therapeutics trades, last 26 weeks

What else happened in Prelude Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/13~25/07/12

Baker Bros. Advisors's other 5% stake reports

  • Baker Bros. Advisors

    5% stakeKodiak Sciences

    35% stake

    Filed 09/30

  • Baker Bros. Advisors

    5% stakeBeOne Medicines

    7.8% stake

    Filed 09/16

  • Baker Bros. Advisors

    5% stakeIdeaya Biosciences

    5.2% stake

    Filed 08/14

  • Baker Bros. Advisors

    5% stakeRevolution Medicines

    5.3% stake

    Filed 08/14

  • Baker Bros. Advisors

    5% stakeImmatics

    7% stake

    Filed 08/14